African-led study expected to involve 1,600 people over next three years in Uganda, Tanzania, Mozambique and South Africa
The first trial in Africa to test two new vaccines to protect against HIV got under way in Uganda this week, raising hopes of an end to the epidemic that affects millions of people across the continent.
The African-led PrEPVacc study will test two experimental combination vaccines to see if they can provide any protection against HIV in people most at risk of infection.
Continue reading…African-led study expected to involve 1,600 people over next three years in Uganda, Tanzania, Mozambique and South AfricaThe first trial in Africa to test two new vaccines to protect against HIV got under way in Uganda this week, raising hopes of an end to the epidemic that affects millions of people across the continent.The African-led PrEPVacc study will test two experimental combination vaccines to see if they can provide any protection against HIV in people most at risk of infection. Continue reading…